Revenio Group
27.4
EUR
-1.79 %
REG1V
NASDAQ Helsinki
Medical Equipment & Services
Health Care
Revenio is a global provider of comprehensive eye care diagnostic solutions. The group offers fast, user-friendly, and reliable tools for diagnosing glaucoma, diabetic retinopathy, and macular degeneration (AMD). Revenio’s ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), fundus imaging devices, and perimeters as well as software solutions under the iCare brand. In 2023, the Group’s net sales totaled EUR 96.6 million, with an operating profit of EUR 26.3 million. Revenio Group Corporation is listed on Nasdaq Helsinki with the trading code REG1V.
Read moreRevenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
Interim report Q2'25
Interim report Q3'25
Risk
Revenio Group Corporation: Managers' Transactions – Anat Loewenstein
Revenio Group Corporation: Managers' Transactions – Riad Sherif
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
PREMIUM account
Revenio Group Corporation: Managers' Transactions – Heli Lindfors
Revenio Group Corporation: Managers' Transactions – Bill Östman
Revenio Group Corporation: Managers' Transactions – Ann-Christine Sundell
Revenio Group Corporation: Managers' Transactions – Pekka Tammela
Revenio Group Corporation: Transfer of the Company's own shares
Revenio Group Corporation: Managers' Transactions – Arne Boye Nielsen

Revenio Q1'25: Exemplary performance

Revenio Interim report 1-3/2025
Revenio Group Corporation: Interim report January 1- March 31, 2025
Modular Finance IR Consensus: Revenio Group – Consensus estimates Q1 2025
